Coronavirus pandemic delay Mylan and Pfizer's generics merge...

Mylan’s merger with Pfizer’s off-patent drug business has been delayed until later this year because of the coronavirus pandemic.

BioNTech shares pop after coronavirus vaccine deal with Pfiz...

As the coronavirus pandemic spreads across the world and the pressure on health system and economies mounts, Pfizer and BioNTech have agreed to jointly develop a vaccine to prevent the infe

Merck, Pfizer’s Bavencio flunks head and neck cancer trial

GSK's Walmsley gets £2.5m pay rise after strong 2019

There can’t be many people in the UK who enjoyed a £2.5 million pay rise this year – but that’s what GlaxoSmithKline boss Emma Walmsley got after a strong year for sales.

The future of real world evidence

Increasing interest in real-world evidence (RWE) across all stakeholder groups has the industry buzzing about its current role in clinical trials and the potential impact of expanded use.

FDA starts review of Pfizer, Lilly’s non-opioid painkiller